Avantor Inc (NYSE:AVTRpA.PFD)
$ 90.81 0 (0%) Market Cap: - Enterprise Value: - PE Ratio: 50.20 PB Ratio: 2.77 GF Score: 76/100

Avantor Inc at JPMorgan Healthcare Conference Transcript

Jan 08, 2024 / 05:45PM GMT
Rachel Marie Vatnsdal Olson
JPMorgan Chase & Co, Research Division - VP & Senior Equity Research Analyst

Perfect. Good morning, everyone. This is Rachel Vatnsdal from the Life Science Tools and Diagnostics team at JPMorgan. Thank you so much for joining us today. On stage, I've got the Avantor team. We're going to start off with your typical presentation around 20 minutes, and then we'll shift to Q&A.

If any of you in the room have a question, I believe we have mic runners. You can also submit your questions on the app or ping me directly. So with that, Michael, I will hand it off to you for the presentation.

Michael Stubblefield
Avantor, Inc. - President, CEO & Director

Great. Thank you, Rachel, and good morning, everyone. Thank you for joining us here to kick off the New Year at the JPMorgan Conference. Again, as you can see, I'm joined here on stage by our CFO, Brent Jones. Also in the audience, we have our Head of Investor Relations, Christina Jones; and Kitty Sahin, our Head of Corporate Strategy, is also with us today.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot